HOME >> MEDICINE >> NEWS
Minors able to buy nicotine replacement therapy products

CHICAGO Although over-the-counter nicotine replacement therapy products like gum and patches have labeling indicating that they are not for sale to minors, these products were successfully purchased by a minor in more than 80 percent of purchase attempts, according to an article in The Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

According to the article, an estimated 28.5 percent of high school students smoke cigarettes and more than half try to quit each year. Public health guidelines recommend that health care providers counsel adolescents to stop smoking, and to try nicotine replacement therapy (NRT, including gum, patches, etc.) to help in smoking cessation. Many NRT products are sold over-the-counter, but the labeling on these items indicates that they should not be sold to anyone under 18 years.

Karen C. Johnson, M.D., M.P.H., from The University of Tennessee Health Science Center, Memphis, and colleagues investigated the ability of a minor to purchase over the counter NRT products.

The researchers identified 165 stores (retail, drug stores and grocery stores) in Memphis that sold over the counter NRT products. A 15-year-old girl visited the stores and attempted to buy NRT. She was instructed not to lie about her age, and carried no identification indicating her age. The minor was accompanied by an adult supervisor who entered the stores separately to observe the purchase attempts. The supervisor had no direct contact with the minor or the sales clerks.

In 81 percent of purchase attempts, the minor was able to purchase NRT. She was not questioned about her age in 79 percent of purchase attempts. The researchers also found that if the clerk asked the girl's age, she was much less likely to be allowed to buy NRT.

"Our study demonstrates that most purchases of NRT were obtained by a minor buyer without proof of age, despite warnings printed on the product," the auth
'"/>

Contact: Elizabeth Maynard-Garrett
901-448-4957
JAMA and Archives Journals
1-Mar-2004


Page: 1 2

Related medicine news :

1. Studies underscore genetic involvement in nicotine addiction & aggressive hostility
2. Brain activity of men and women during hostile or impulsive acts differs less on nicotine
3. Animal study shows link between nicotine and atrial flutter
4. Free nicotine patches increase short-term smoking quit rates
5. Brains nicotine receptors also target for anti-depressants
6. Antidepressant may help people stop smoking when used with nicotine patch
7. Majority of cigarettes in the US smoked by nicotine-dependent or psychiatrically ill persons
8. Reduced exposure tobacco products lessen carcinogen exposure, but medicinal nicotine better
9. Success of nicotine patches linked to genetic make-up
10. Study supports new theory for nicotines protective effect against neurodegenerative disorders
11. Early nicotine use may lead to lasting addiction, study finds

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Minors able buy nicotine replacement therapy products

(Date:10/22/2014)... October 22, 2014 Akeso Biomedical, ... for the treatment of bacterial infections, microbial biofilms, and ... joined its board of directors. , Dr. ... Systems at The Massachusetts Institute of Technology, or MIT. ... since 1968. Dr. Sinskey also holds positions as Co-Director ...
(Date:10/22/2014)... Tara Haelle HealthDay Reporter ... drinking among young adult men may lead to increased blood ... didn,t cause a similar rise in blood pressure for young ... fact, when young adult women drank lightly or moderately, their ... study found. "This finding parallels studies in older adult ...
(Date:10/22/2014)... Dennis Thompson HealthDay Reporter ... was diagnosed with Ebola while working for NBC News ... leave the special isolation unit at Nebraska Medical Center in Omaha, ... hospital said Tuesday. A blood test confirmed by the U.S. ... can head home to Providence, R.I., NBC News reported ...
(Date:10/20/2014)... October 20, 2014 The Advocator ... booth at the American Foundation for Suicide Prevention’s (AFSP) ... AFSP is a not-for-profit organization that hosts hundreds of ... from these events are used to help understand and ... and personal relationships as well. , The Advocator ...
(Date:10/20/2014)... 20, 2014 hc1.com today announced ... cloud solution that enables healthcare organizations of all ... healthcare-specific customer relationship management (“CRM”) solution. , Designed ... needs of the healthcare industry, the hc1 Healthcare ... and patients by combining healthcare CRM, HIPAA-compliant collaboration, ...
Breaking Medicine News(10 mins):Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 2Health News:U.S. Cameraman Treated for Ebola 'Free' of the Virus 3Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2
(Date:10/22/2014)... SAN DIEGO , Oct. 21, 2014 /PRNewswire/ ... announced today the latest genomics research centers to ... the Salk Institute, the National Cancer Institute (NCI), ... National Sequencing Center). Before Irys, obtaining a comprehensive ... because next generation sequencing (NGS) does not deliver ...
(Date:10/22/2014)... -- InVivo Therapeutics Holdings Corp. (OTCQB: NVIV) based in ... cord injury (SCI) treatment with their novel Neuro-Spinal Scaffold. ... regrowth in the spinal cord area when cells are ... polymer, the scaffold ultimately breaks down to water and ... NVIV has recently attracted significant investor attention with the ...
(Date:10/22/2014)... REDWOOD CITY, Calif. , Oct. 22, 2014 ... ) today announced that results from the  IAP310 ... and Pain Medicine (RAPM), a peer-reviewed journal ... placebo-controlled, Phase 3 trial evaluating the safety and ... sufentanil sublingual tablet system (SSTS), for the treatment ...
Breaking Medicine Technology:BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 2InVivo Therapeutics Analyst Coverage Initiated: Analyst Report by BrokerBank Securities, Inc. 3AcelRx Announces Publication of Zalviso Phase 3 Abdominal Trial Results 2
Cached News: